Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: Blockage of the paracrine effect and receptor binding of transforming growth factor β1 and platelet-derived growth factor-BB

Cell Growth and Differentiation

Volumn 9, Issue 6, 1998, Pages 497-504

  Bagheri Yarmand, Rozita ^a   Kourbali, Yamina ^a   Morère, Jean François ^b   Jozefonvicz, Jacqueline ^a   Crépin, Michel ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b Clin Univ de Cancérologie

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; CELL SURVIVAL; COMPLEX FORMATION; DNA SYNTHESIS INHIBITION; DRUG RECEPTOR BINDING; EXTRACELLULAR MATRIX; FIBROBLAST; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MITOGENESIS; ONCOGENE RAS; PRIORITY JOURNAL; TUMOR GROWTH; XENOGRAFT;

3T3 CELLS; ANIMALS; ANTIBODIES; ANTICOAGULANTS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CULTURE MEDIA, CONDITIONED; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031845838     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Sporn, M. B., and Roberts, A. B. Autocrine growth factors and cancer. Nature (Lond.), 313: 745-747, 1985.
2. Cross, M., and Dexter, T. M. Growth factors in development, transformation, and tumorigenesis. Cell, 64: 271-280, 1991.
3. Cullen, K. J., and Lippman, M. E. Stromal-epithelial interactions in breast cancer. Cancer Treat. Res., 61: 413-431, 1992.
4. Sporn, M. B., and Roberts, A. B. Peptide growth factors are multifunctional. Nature (Lond.), 332: 217-219, 1988.
5. Bates, S. E., McManaway, M. E., Lippman, M. E., and Dickson, R. B. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res., 46: 1707-1713, 1986.
6. Huff, K. K., Kaufman, D., Gabby, K. H., Spencer, E. M., Lippman, M. E., and Dickson, R. B. Secretion of an insulin-like growth factor 1 related protein by human breast cancer cells. Cancer Res., 46: 4613-4619, 1986.
7. Knabbe, C., Wakefield, L., Flanders, K., Kasid, A., Derynck, R., Lippman, M. E., and Dickson, R. B. Evidence that TGFβ is a hormonally regulated negative growth factor in human breast cancer. Cell, 48: 417-428, 1987.
8. Bronzert, K., Pantazis, P., Antoniades, H. N., Kasid, A., Davidson, N., Dickson, R. B., and Lippman, M. E. Synthesis and secretion of platelet- derived growth factor by human breast cancer cell lines. Proc. Natl. Acad. Sci. USA., 84: 5763-5767, 1987.
9. Kao, R. T., Hall, J., Engel, L., and Stern, R. The matrix of human breast tumor cells is mitogenic for fibroblasts. Am. J. Pathol., 115: 109-116, 1984.
10. Ross, R., Raines, E. W., and Bowen-Pope, D. F. The biology of platelet-derived growth factor. Cell, 46: 155-169, 1986.
11. Rozengurt, E., Sinnett-Smith, J., and Taylor-Papadimitriou J. Production of PDGF-like growth factor by breast cancer cell lines. Int. J. Cancer, 36: 247-252, 1985.
12. Stiles, C. D., Capone, G. T., Scher, C. D., Antoniades, H. N., Van Wky, J. J., and Pledger, W. J. Dual control of cell growth by somatomedins and platelet-derived growth factor, Proc. Natl. Acad. Sci. USA, 76: 1279- 1283, 1979.
13. Assoian, R.k., Grotendorst, G. R., Miller, D. M., and Sporn, M. B. Cellular transformation by coordinated action of tripeptide growth factors from human platelets. Nature (Lond.), 309: 804-806, 1984.
14. Arteaga, C. L., Carty-Dugger, T., Moses, H. L., Hurd, S. D., and Pietenpol, J. A. Transforming growth factor β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ., 4:193-201, 1993.
15. Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., and Akhurst, R. J. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86: 531-542, 1996.
16. Arrick, B. A., Lopez, A. R., Elfman, F., Ebner, R., Damsky, C. H., and Derynck, R. Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J. Cell Biol., 118: 715-726, 1992.
17. Chakrabarty, S. Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor β1. Int. J. Cancer, 50: 968-973, 1992.
18. Samuel, S. R., Hurta, R. A. R., Kondaiah, P., Khalil, N., Turley, E. A., Wright, J. A., and Greenberg, A. H. Autocrine induction and tumour prolease production and invasion by a metalloproteinase-regulated TGFβ1. EMBO J., 11: 1599-1605, 1992.
19. Chang, H. L., Gillett, N., Figaro, I., Lopez, A. R., Palladino, M. R., and Derynck, R. Increased transforming growth factor β expression inhibits cell proliferation in vitro yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res., 53: 4391-4398, 1993.
20. Wang, D., Zhou, G., Birkenmeier, T. M., Gong, J., Sun, L., and Brattain, M. G. Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells. J. Biol. Chem., 270: 14154-14159, 1995.
21. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Röche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H., and Fauci, A. S. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA, 83: 4167-4171, 1986.
22. Torre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., and Rowley, D. A. A highly immunogenic tumor transfected with a murine transforming growth factor type β-1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA, 87: 1486-1490, 1990.
23. Arteaga, C. L, Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., and Forbes, J. T. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer activity. J. Clin. Invest., 92: 2569-2576, 1993.
24. 2+ signaling by dextran sulfates of different sizes and degrees of sulfation. Cancer Chemother. Pharmacol., 30: 483- 486, 1992.
25. Wright, T. C., Johnstone, T. V., and Castellot, J. J. Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J. Cell. Physiol., 125: 499-506, 1985.
26. Stein, C. A. Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res., 53: 2239-2248, 1993.
27. Zugmaier, G., Lippman, M. E., and Wellstein, A. Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J. Natl. Cancer Inst. (Bethesda), 84: 1716-1724, 1992.
28. Chaubet, F., Champion, J., Maïga, R., Maurey, S., and Jozefonvicz, J. Synthesis and structure-anticoagulant property relationships of functionalized dextrans: CMDBS. Carbohydrate Polymers, 28: 145-152, 1995.
29. Mauzac, M., Maillet, F., Jozefonvicz, J., and Kazatchkine, M. D. Anticomplementary activity of dextran derivatives. Biomaterials, 6: 61-63, 1985.
30. Crepon, B., Maillet, F., Kazatchkine, M. D., and Jozefonvicz, J. Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans. Biomaterials, 8: 248-253, 1987.
31. Bagheri-Yarmand, R., Bittoun, P., Champion, J., Letourneur, D., Jozefonvicz, J., Fermandjian, S., and Crépin, M. Carboxymethyl benzylamide dextrans inhibit breast cell growth. In Vitro Cell Biol., 30A: 822-824, 1994.
32. Morère, J. F., Planchon, P., Letourneur, D., Avramoglou, T., Jozefonvicz, J., Israel, L., and Crépin, M. Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro. Anticancer Drugs, 3: 629-634, 1992.
33. Liu, J. F., Bagheri-Yamand, R., Xia, Y., and Crépin, M. Modulations of breast fibroblast and carcinoma cell interactions by a dextran derivative (CMDB7). Anticancer Res., 17: 253-258, 1997.
34. Bagheri-Yarmand, R., Liu, J. F., Ledoux, L., Morère, JF., Crépin, M. Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): interference with the FGF2 autocrine loop. Biochem. Biophys. Res. Commun., 239: 424-428, 1997.
35. Jackson, J. A., Holt, J. T., and Pledger, W. J. Platelet-derived growth factor regulation of fos stability correlates with growth induction. J. Biol. Chem., 267: 17444-17448, 1992.
36. Lubinus, M., Meier, K. E., Smith, E. A., Gause, K. C., LeRoy, E. C., and Trojanowska, M. Independent effects of platelet-derived growth factor isoforms on mitogen-activated protein kinase activation and mitogenesis in human dermal fibroblasts. J. Biol. Chem., 269: 9822-9825, 1994.
37. Chatani, Y., Tanimura, S., Miyoshi, N., Hattori, A., Sato, M., and Kohno, M. Cell type-specific modulation of cell growth by transforming growth factor β1 does not correlate with mitogen-activated protein kinase activation. J. Biol. Chem., 270: 30686-30692, 1995.
38. 27kip by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J. Biol. Chem., 267: 11253-11260, 1996.
39. H. Cancer Res., 50: 67-71, 1990.
40. De-Quan, L., and Scheffer, C. G. T. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J. Cell. Physiol., 163: 61-79, 1995.
41. Dickson, R. B., and Lippman M. E. Growth factors in breast cancer. Endocr. Rev., 16: 559-590, 1995.
42. Dickson, R. B., McManaway, M., and Lippman M. E. Estrogen induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science (Washington DC), 232: 1540-1543, 1986.
43. Dickson, R. B., Kasid, A., Huff, K. K., Bates, S. E., Knabbe, C., Bronzert, D., Gelmann, E. P., and Lippman, M. E. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β- estradiol or v-Ha-ras oncogene. Proc. Natl. Acad. Sci. USA, 84: 837-841, 1987.
44. Peres, R., Betsholtz, C., Westermark, B., and Heldin, C. H. Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res., 47: 3425-3429, 1987.
45. 1 phase of the cell cycle in BALB/C3T3 murine fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 3889- 3893, 1992.
46. Dickson, R. B., and Lippman, M. E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr. Rev., 8: 29-43, 1987.
47. Cullen, K. J., Yee, D., Sly, W. S., Perdu, J., Hampton, B., Lippman, M. E., and Rosen, N. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res., 50: 48-53, 1990.
48. Lee, M. K., and Lander, A. D. Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach. Proc. Natl. Acad. Sci. USA, 88: 2768-2772, 1991.
49. Massagué, J., and Like, B. Cellular receptors for type β transforming growth factor. J. Biol. Chem., 260: 2636-2645, 1985.
50. Ueki, N., Nakazato, M., Ohkawa, T., Ikeda, T., Amuro, Y., Hada, T., and Higashino, K. Excessive production of TGFβ1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumorigenesis tumor growth. Biochim. Biophys. Acta, 1137: 189-196, 1992.
51. Yang, E. Y., and Moses, H. L. Transforming growth factor β1 induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell. Biol., 111: 731-741, 1990.
52. Fajardo, L. F., Prionas, S. D., Kwan, H. H., Kowalski, J., and Allison, A. C. Transforming growth factor β-1 induces angiogenesis in vivo with a threshold pattern. Lab. Invest., 74: 600-608, 1996.
53. Battegay, E., Rupp, J., Irula-Arispe, L., Sage, H., and Pech, M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGFβ-receptor. J. Cell. Biol., 125: 917-928, 1994.
54. Thommen, R., Humar, R., Misevic, G., Pepper, M. S., Hahn, A. W., John, M., and Battegay, E. J. PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro. J. Cell. Biochem., 64: 403-413, 1997.
55. Bagheri-Yarmand, R., Kourbali, Y., Mabilat, C., Morère, J. F., Martin, A., Lu, H., Soria, C., Jozefonvicz, J., and Crépin, M. The suppression of FGF2/FGF4 dependent tumour angiogenesis and growth by the antigrowth factor activity of dextran derivative (CMDB7). Br. J. Cancer, in press, 1998.